Fabino Enterprises
FABINOLTD NSE
Fabino Enterprises
HealthcareNSE: FABINOLTD BSE: 543444 Pharmaceuticals
Key Fundamentals
SMEPharmaceuticalsHealthcareMarket Cap
₹4.30 Cr
Volatility
Low Risk
P/E Ratio
-7.6
EBITDA
₹-2.06 Cr
Return on Equity
1.45%
Debt to Equity
0.44
Book Value
₹17.38
EPS
₹0.17
52W High
₹27
52W Low
₹13.01
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Stock is trading at 1.17 times its book value
Weaknesses
4- Company has low interest coverage ratio.
- Company has a low return on equity of -3.76% over last 3 years.
- Company might be capitalizing the interest cost
- Company has high debtors of 288 days.
Growth Rate
Revenue Growth
13.88% lower than
3Y
Net Income Growth
-840%
Cash Flow Change
116% higher than
3Y
ROE
68.6% higher than
3Y
ROCE
231%
EBITDA Margin (Avg.)
-522%
Quarterly Results
| Particulars | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 2.32 | 12.86 | 8.22 | 4.25 | 13.78 | 6.63 | 14.21 |
| Expenses | 2.3 | 12.74 | 8.23 | 4.22 | 13.7 | 6.95 | 15.96 |
| Operating Profit | 0.02 | 0.12 | -0.01 | 0.03 | 0.08 | -0.32 | -1.75 |
| OPM % | 0.86% | 0.93% | -0.12% | 0.71% | 0.58% | -4.83% | -12.32% |
| Other Income | 0 | 0.01 | 0 | 0.11 | 0.18 | 0.28 | 1.29 |
| Interest | 0 | 0 | 0.03 | 0.06 | 0.07 | 0.09 | 0.04 |
| Depreciation | 0.02 | 0.01 | 0.03 | 0.04 | 0.04 | 0.06 | 0.05 |
| PBT | 0 | 0.12 | -0.07 | 0.04 | 0.15 | -0.19 | -0.55 |
| Tax % | — | 25% | -28.57% | 25% | 80% | 0% | -32.73% |
| Net Profit | 0 | 0.09 | -0.05 | 0.03 | 0.03 | -0.19 | -0.37 |
| EPS in Rs | 0 | 0.43 | -0.24 | 0.14 | 0.14 | -0.9 | -1.76 |
Profit & Loss
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 3.36 | 21.01 | 17.98 | 20.84 |
| Expenses | 3.33 | 20.89 | 17.87 | 22.9 |
| Operating Profit | 0.03 | 0.12 | 0.11 | -2.06 |
| OPM % | 0.89% | 0.57% | 0.61% | -9.88% |
| Other Income | 0.02 | 0.01 | 0.29 | 1.56 |
| Interest | 0.01 | 0.04 | 0.13 | 0.13 |
| Depreciation | 0.03 | 0.04 | 0.08 | 0.11 |
| PBT | 0.01 | 0.05 | 0.19 | -0.74 |
| Tax % | 0% | 20% | 68.42% | -24.32% |
| Net Profit | 0.01 | 0.04 | 0.06 | -0.56 |
| EPS in Rs | 0.05 | 0.19 | 0.29 | -2.67 |
| Div. Payout % | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 2.1 | 2.1 | 2.1 | 2.1 |
| Reserves | 2.01 | 2.04 | 2.1 | 1.55 |
| Borrowings | 0.41 | 1.27 | 1.79 | 1.62 |
| Other Liabilities | 0.5 | 9.95 | 11.67 | 16.87 |
| Total Liabilities | 5.02 | 15.36 | 17.66 | 22.14 |
| Fixed Assets | 0.15 | 0.34 | 0.55 | 0.37 |
| CWIP | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets | 4.87 | 15.02 | 17.11 | 21.77 |
| Total Assets | 5.02 | 15.36 | 17.66 | 22.14 |
Cash Flow
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Operating | -0.68 | -0.77 | 0.12 | 0.19 |
| Investing | -0.01 | -0.28 | -0.42 | 0.07 |
| Financing | 0.34 | 0.86 | 0.48 | -0.3 |
| Net Cash Flow | -0.35 | -0.18 | 0.18 | -0.05 |
| Free Cash Flow | -0.69 | -1.01 | -0.17 | 0.26 |
| CFO/OP | -2,233 | -633 | 227 | -9 |
Ratios
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Debtor Days | 275 | 219 | 288 | 288 |
| Inventory Days | 147 | 24.21 | 26.56 | 19.14 |
| Days Payable | 45.78 | 179 | 253 | 297 |
| Cash Conversion Cycle | 376 | 63.97 | 61.44 | 9.98 |
| Working Capital Days | 444 | 86.34 | 104 | 78.29 |
| ROCE % | — | 1.81% | 5.61% | -10.83% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Fabino Enterprises insights
52 extracted metrics + investor summaries across FY22–FY26.
Documents
1
Detailed Public Statement
6 May - R G Family Trust and Gupta brothers announce open offer for 5,46,000 Fabino shares at ₹20 each. 6 May - R G Family Trust and Gupta brothers announce open offer for 5,46,000 Fabino shares at ₹20 each.
2
Public Announcement - Open Offer
28 Apr - Aryaman Financial Services Ltd ("Manager to the Offer") has submitted to BSE a copy of Public Announcement under Regulations 3(1) and 4 read with Regulations … 28 Apr - Aryaman Financial Services Ltd ("Manager to the Offer") has submitted to BSE a copy of Public Announcement under Regulations 3(1) and 4 read with Regulations …
3
Public Announcement - Open Offer
28 Apr - Aryaman Financial Services Ltd ("Manager to the Offer") has submitted to BSE a copy of Public Announcement under Regulations 3(1) and 4 read with Regulations … 28 Apr - Aryaman Financial Services Ltd ("Manager to the Offer") has submitted to BSE a copy of Public Announcement under Regulations 3(1) and 4 read with Regulations …
5
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
11 Apr - Company confirms it is not a Large Corporate as of 31 March 2026; no FY27 disclosure required. 11 Apr - Company confirms it is not a Large Corporate as of 31 March 2026; no FY27 disclosure required.
Frequently Asked Questions about Fabino Enterprises
What does Fabino Enterprises Ltd do?
Incorporated in 2011, Fabino Enterprises manufactures, markets, trades, and does packing of pharmaceutical and other wellness focused consumer products[1]
Where is Fabino Enterprises Ltd (543444) listed?
Fabino Enterprises Ltd trades as FABINOLTD on the NSE and under code 543444 on the BSE.
Which sector does Fabino Enterprises Ltd belong to?
Fabino Enterprises Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Fabino Enterprises Ltd?
Fabino Enterprises Ltd has a market capitalisation of ₹4.3 Cr, which places it in the Small Cap band.
What is the PE ratio of Fabino Enterprises Ltd?
Fabino Enterprises Ltd trades at a PE ratio of -7.60, on earnings per share of ₹0.17, against a book value of ₹17.38 per share.
What is the 52-week high and low of Fabino Enterprises Ltd?
Over the last 52 weeks Fabino Enterprises Ltd has traded between ₹13.01 and ₹27.
What is the Return on Equity (ROE) of Fabino Enterprises Ltd?
Fabino Enterprises Ltd reported a return on equity of 1.45%. Its debt-to-equity ratio is 0.44.
Company Information
Incorporated in 2011, Fabino Enterprises manufactures, markets, trades, and does packing of pharmaceutical and other wellness focused consumer products[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/543444.md for Fabino Enterprises Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.